Description Usage Format Details Source
Liver related laboratory data from a randomized, blind, parallel group clinical trial with 4 doses of a drug.
1 |
A data frame with 606 observations on the following 9 variables.
ALP.B
Alkaline phosphatase at baseline. A numeric vector.
ALT.B
Alanine aminotransferase at baseline. A numeric vector.
AST.B
Aspartate aminotransferase at baseline. A numeric vector.
TBL.B
Total bilirubin at baseline. A numeric vector.
ALP.M
Alkaline phosphatase after treatment. A numeric vector.
ALT.M
Alanine aminotransferase after treatment. A numeric vector.
AST.M
Aspartate aminotransferase after treatment. A numeric vector.
TBL.M
Total bilirubin after treatment. A numeric vector.
dose
The treatment group (i.e. dose group). A factor with levels A
B
C
D
Dose A is the lowest dose, dose, B the next, C the next, and D the highest dose. The baseline values were taken prior to any treatment being received, and the clinical trial had a single post-baseline visit.
AstraZeneca data on file.
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.